CD54 upregulation is just one of the many metrics that they use to measure the potency of the product and the product can be made for anyone having PC or not. So it isn't clear how it could be used as surrogate endpoint. But wouldn't the statement on analyzing it as a continuous variable yielding a significant correlation with survival more or less satisfy what you are asking?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.